These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 31723226)

  • 21. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of epigenetic dysregulation gene markers and immune landscape in kidney renal clear cell carcinoma by comprehensive genomic analysis.
    Xie L; Wu S; He R; Li S; Lai X; Wang Z
    Front Immunol; 2022; 13():901662. PubMed ID: 36059531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of methylation-driven genes related to prognosis in clear-cell renal cell carcinoma.
    Wang J; Zhang Q; Zhu Q; Liu C; Nan X; Wang F; Fang L; Liu J; Xie C; Fu S; Song B
    J Cell Physiol; 2020 Feb; 235(2):1296-1308. PubMed ID: 31273792
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Integrative Analysis of Histopathological Images and Genomic Data Predicts Clear Cell Renal Cell Carcinoma Prognosis.
    Cheng J; Zhang J; Han Y; Wang X; Ye X; Meng Y; Parwani A; Han Z; Feng Q; Huang K
    Cancer Res; 2017 Nov; 77(21):e91-e100. PubMed ID: 29092949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrative -omics and HLA-ligandomics analysis to identify novel drug targets for ccRCC immunotherapy.
    Reustle A; Di Marco M; Meyerhoff C; Nelde A; Walz JS; Winter S; Kandabarau S; Büttner F; Haag M; Backert L; Kowalewski DJ; Rausch S; Hennenlotter J; Stühler V; Scharpf M; Fend F; Stenzl A; Rammensee HG; Bedke J; Stevanović S; Schwab M; Schaeffeler E
    Genome Med; 2020 Mar; 12(1):32. PubMed ID: 32228647
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Using Genomic and Transcriptome Analyses to Identify the Role of the Oxidative Stress Pathway in Renal Clear Cell Carcinoma and Its Potential Therapeutic Significance.
    Che X; Qi X; Xu Y; Wang Q; Wu G
    Oxid Med Cell Longev; 2021; 2021():5561124. PubMed ID: 34721758
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Assessing the clinical use of clear cell renal cell carcinoma molecular subtypes identified by RNA expression analysis.
    Eckel-Passow JE; Igel DA; Serie DJ; Joseph RW; Ho TH; Cheville JC; Parker AS
    Urol Oncol; 2015 Feb; 33(2):68.e17-23. PubMed ID: 25175426
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
    Xu L; He J; Cai Q; Li M; Pu X; Guo Y
    Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Key miRNAs and target genes played roles in the development of clear cell renal cell carcinoma.
    Liu J; Liu B; Guo Y; Chen Z; Sun W; Gao W; Wu H; Wang Y
    Cancer Biomark; 2018; 23(2):279-290. PubMed ID: 30198869
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The biological roles and clinical implications of microRNAs in clear cell renal cell carcinoma.
    He YH; Chen C; Shi Z
    J Cell Physiol; 2018 Jun; 233(6):4458-4465. PubMed ID: 29215721
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An integrative genomics approach for identifying novel functional consequences of PBRM1 truncated mutations in clear cell renal cell carcinoma (ccRCC).
    Wang Y; Guo X; Bray MJ; Ding Z; Zhao Z
    BMC Genomics; 2016 Aug; 17 Suppl 7(Suppl 7):515. PubMed ID: 27556922
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Type 1 and 2 papillary renal cancers are genetically distinct.
    Balakrishnan VS
    Lancet Oncol; 2015 Dec; 16(16):e594. PubMed ID: 26596671
    [No Abstract]   [Full Text] [Related]  

  • 35. Identification of Ligand-Receptor Pairs Associated With Tumour Characteristics in Clear Cell Renal Cell Carcinoma.
    Liu F; Wang P; Sun W; Jiang Y; Gong Q
    Front Immunol; 2022; 13():874056. PubMed ID: 35734169
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative analysis of DNA methylation and gene expression in papillary renal cell carcinoma.
    Singh NP; Vinod PK
    Mol Genet Genomics; 2020 May; 295(3):807-824. PubMed ID: 32185457
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of Six Potentially Long Noncoding RNAs as Biomarkers Involved Competitive Endogenous RNA in Clear Cell Renal Cell Carcinoma.
    Yang K; Lu XF; Luo PC; Zhang J
    Biomed Res Int; 2018; 2018():9303486. PubMed ID: 30406146
    [No Abstract]   [Full Text] [Related]  

  • 38. Integrative Analysis of Multi-Genomic Data for Kidney Renal Cell Carcinoma.
    Singh A; Goel N; Yogita
    Interdiscip Sci; 2020 Mar; 12(1):12-23. PubMed ID: 31392539
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pyroptosis relates to tumor microenvironment remodeling and prognosis: A pan-cancer perspective.
    Khan M; Ai M; Du K; Song J; Wang B; Lin J; Ren A; Chen C; Huang Z; Qiu W; Zhang J; Tian Y; Yuan Y
    Front Immunol; 2022; 13():1062225. PubMed ID: 36605187
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.